AlphaGrep UK’s Arcosa ACA Stock Holding History

AlphaGrep UK’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,458	Closed	-$368K	–	761
2025 Q4	$368K	Buy	+3,458	New	+$349K	0.12%	321

Other funds holding ACA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AlphaGrep UK's ACA Position: Q1 2026 in Review

AlphaGrep UK sold out of Arcosa (ACA) in Q1 2026, closing a stake of 3,458 shares — an estimated $368K sold.

AlphaGrep UK first reported a position in ACA in Q4 2025 and held it in 1 quarter. The position peaked at $368K in Q4 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

AlphaGrep UK reported no remaining Arcosa position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK sold 3,458 Arcosa shares in Q1 2026, an estimated $368K.
AlphaGrep UK first reported a position in Arcosa in Q4 2025 and held it in 1 quarter.
AlphaGrep UK's Arcosa position peaked at $368K in Q4 2025.
372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on AlphaGrep UK's 13F filing for Q1 2026, filed 13 Aug 2026.